Objective: Similarities between rheumatoid arthritis (RA) and atherosclerosis include endothelial dysfunction (an antecedent of plaque formation) and depletion of circulating bone marrow–derived endothelial progenitor cells. This study was undertaken to test the hypothesis that endothelial progenitor cell depletion and subclinical atherosclerosis in RA may be related to accumulation of an endogenous inhibitor of nitric oxide (NO) synthesis, asymmetric dimethyl‐L‐arginine.Methods: We studied 30 patients with active RA and 20 age‐ and sex‐matched healthy controls. Exclusion criteria were clinically evident atherosclerosis, traditional risk factors, hyperhomocysteinemia, and renal dysfunction. The blood endothelial progenitor cell count was assayed by flow cytometry and expressed as a percentage of lymphocytes. PlasmaL‐arginine, asymmetric dimethyl‐L‐arginine, and symmetric dimethyl‐L‐arginine were measured with liquid chromatography–mass spectrometry. Mean carotid intima‐media thickness (IMT) was assessed by B‐mode ultrasound.Results: In RA patients, we found elevated levels of asymmetric dimethyl‐L‐arginine (mean ± SD 0.49 ± 0.07 μmoles/liter versus 0.40 ± 0.07 μmoles/liter in controls;P< 0.001), a depressed endothelial progenitor cell count (0.039 ± 0.025% versus 0.063 ± 0.035%;P< 0.05), and increased IMT (0.65 ± 0.13 mm versus 0.55 ± 0.10 mm;P< 0.01), with no differences in levels ofL‐arginine or symmetric dimethyl‐L‐arginine. The endothelial progenitor cell count was inversely correlated with the level of asymmetric dimethyl‐L‐arginine. IMT was positively related to the ratio of asymmetric dimethyl‐L‐arginine toL‐arginine and negatively related to the endothelial progenitor cell count, in univariate and multivariate analyses.Conclusion: Plasma asymmetric dimethyl‐L‐arginine levels are elevated in RA patients free of cardiovascular disease or risk factors. Asymmetric dimethyl‐L‐arginine accumulation may contribute to endothelial progenitor cell depletion via depressed NO‐dependent endothelial progenitor cell mobilization and/or survival, with consequent impairment of endothelial progenitor cell–mediated endothelial repair, which can promote atherogenesis in RA.
There are conflicting data on the clinical outcomes of percutaneous coronary intervention (PCI) for ST-segment elevation myocardial infarction (STEMI) based on the time of admission to the catheterization laboratory. Thus, we aimed to assess clinical outcomes in an unselected cohort of consecutive patients with STEMI treated with PCI during on- and off-hours of work. A total of 99,783 patients were included in the analysis. Patients were divided using the most frequently used definition: On-hours (Monday-Friday 07:00 AM-04:59 PM); off-hours (Monday-Friday 05:00 PM-06:59 AM, Saturday, Sunday and nonworking Holidays)(37,469 matched pairs) To avoid potential preselection bias, a propensity score was calculated to compare on- and off-hours group. Higher radiation doses were observed for PCIs performed during off-hours (1055.2(±1006.5) vs. 1081.6(±1003.25)[mGy], p=0.001). A similar prevalence of periprocedural complications was observed during on- and off-hours. However, there was a higher mortality rate during off-hours compared to regular working hours ( 1.17% (439) vs. 1.49% (559), p=0.001). Primary PCIs in STEMI performed during off-hours might be associated with a higher rate of periprocedural mortality and higher radiation doses than procedures conducted during regular working hours.